USPTO serial 88470347
CHONG KUN DANG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2020
- Examiner
- LEVINE, HOWARD B
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CHONG KUN DANG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith BIRCH, STEWART, KOLASCH & BIRCH, LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Vitamin preparations; Antibiotic preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating respiratory diseases; Allergy medications; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Cardiovascular agents for medical purposes; Amino acids for medical purposes; Dermatological pharmaceutical preparations; Ophthalmic preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations, namely, antivirals; Tumor suppressing agents; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of hyperlipidemia; Anti-inflammatories; Analgesics; Bacterial poisons; Pharmaceutical preparations for the treatment of cellular disorders; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in urology; Vaccines; Nutritional supplements, namely, tonics and alternatives for medical purposes; Antibiotics; pharmaceutical preparation for the arthritis treatment; pharmaceutical preparation for the rheumarthritis treatment; Anti-cancer preparations; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Health food supplement mainly based on lactic acid bacteria; ] Nutritional supplements, namely, probiotic compositions; [ Lactic acid bacteria in the form of capsules for medical purpose; Lactose for medical purposes; Powdered milk for babies; Calcium supplements; Powdered nutritional supplement drink mixes; ] Probiotic supplements; [ Pharmaceutical preparations for use in the treatment of diabetes, anemia, cardiovascular disease, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Nutraceutical preparations for therapeutic or medical purposes in the treatment of gout; nutraceuticals for use as a dietary supplement; Anti-oxidant food supplements; Food supplements, namely, anti-oxidants; ] Food supplements [; Dietary supplements; Medicated food supplements ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CHONG KUN DANG HOLDINGS CORP.
- Other trademarks owned by CHONG KUN DANG HOLDINGS CORP.
- Other trademarks owned by CHONG KUN DANG HOLDINGS CORP.
- Other trademarks in Class 005
- Similar marks named CHONG KUN DANG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 21, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 16, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 6, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 6, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 2, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 2, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 2, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 1, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 25, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2019 | NWAP | NEW APPLICATION ENTERED | — |